A biotechnology drug developer focused on treatments for cancer, immune disorders, and inflammatory diseases. Its portfolio historically included blockbuster therapies such as Revlimid and Pomalyst for blood cancers, making the company a major player in oncology drug markets. Investors closely follo...
16 members of Congress have disclosed 50 trades in Celgene Corporation (CELG), a Healthcare company. The buy/sell breakdown shows 29 purchases versus 21 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-08-16 | JAMES B. RENACCI | buy | $15K – $50K |
| 2017-08-01 | Pat Roberts | buy | $15K – $50K |
| 2017-06-28 | MICHAEL T. MCCAUL | sell | $100K – $250K |
| 2017-06-15 | ZOE LOFGREN | buy | $1K – $15K |
| 2017-05-24 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2017-05-16 | David P. Roe | buy | $1K – $15K |
| 2017-05-05 | MICHAEL T. MCCAUL | sell | $15K – $50K |
| 2017-04-10 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2017-04-10 | Gary Palmer | buy | $1K – $15K |
| 2017-04-04 | Gary Palmer | buy | $1K – $15K |
| 2017-03-30 | Harold Dallas Rogers | buy | $1K – $15K |
| 2017-03-14 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2017-02-21 | John F Reed | buy | $1K – $15K |
| 2017-02-16 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2017-01-25 | MICHAEL T. MCCAUL | sell | $50K – $100K |
| 2017-01-09 | Bradley S. Schneider | buy | $100K – $250K |
| 2016-10-14 | ALAN S. LOWENTHAL | sell | $1K – $15K |
| 2016-10-14 | ALAN S. LOWENTHAL | sell | $1K – $15K |
| 2016-10-05 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2016-09-12 | K. Michael Conaway | sell | $1K – $15K |
| 2016-08-04 | CHARLES J. "CHUCK" FLEISCHMANN | buy | $1K – $15K |
| 2016-08-04 | Kurt Schrader | buy | $1K – $15K |
| 2016-08-04 | K. Michael Conaway | buy | $1K – $15K |
| 2016-08-03 | K. Michael Conaway | buy | $1K – $15K |
| 2016-07-25 | John F Reed | buy | $1K – $15K |
| 2016-07-20 | JAMES B. RENACCI | sell | $15K – $50K |
| 2016-06-15 | MICHAEL T. MCCAUL | sell | $50K – $100K |
| 2016-05-02 | E. Scott Rigell | sell | $15K – $50K |
| 2016-05-01 | Vern Buchanan | buy | $1K – $15K |
| 2016-03-17 | ALAN S. LOWENTHAL | buy | $1K – $15K |
| 2016-03-14 | JAMES B. RENACCI | sell | $1K – $15K |
| 2016-03-08 | E. Scott Rigell | buy | $15K – $50K |
| 2016-03-07 | ALAN S. LOWENTHAL | buy | $1K – $15K |
| 2016-02-18 | JAMES B. RENACCI | sell | $1K – $15K |
| 2016-02-18 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2016-02-11 | John F Reed | buy | $1K – $15K |
| 2016-02-02 | Vern Buchanan | sell | $1K – $15K |
| 2016-02-01 | John A. Yarmuth | buy | $1K – $15K |
| 2016-01-28 | ALAN S. LOWENTHAL | buy | $1K – $15K |
| 2016-01-27 | JAMES B. RENACCI | buy | $1K – $15K |
| 2016-01-26 | ALAN S. LOWENTHAL | buy | $1K – $15K |
| 2016-01-21 | JAMES B. RENACCI | sell | $1K – $15K |
| 2016-01-11 | JAMES B. RENACCI | buy | $1K – $15K |
| 2015-12-18 | MICHAEL T. MCCAUL | sell | $15K – $50K |
| 2015-12-15 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2015-12-07 | JAMES B. RENACCI | sell | $1K – $15K |
| 2015-10-06 | MICHAEL T. MCCAUL | sell | $50K – $100K |
| 2015-09-30 | JAMES B. RENACCI | buy | $1K – $15K |
| 2015-09-17 | JAMES B. RENACCI | buy | $1K – $15K |
| 2015-09-16 | JAMES B. RENACCI | buy | $1K – $15K |